It is assumed that it functions as a tumor-suppressor gene in several human cancer types: decreased expression level of PITX1 is observed in various malignant tumors, e.g., HNSCC [48,49], gastric cancer [50], lung cancer [51], and colorectal carcinoma [52]. This evidence concerns the gene PITX1 and head and neck squamous cell carcinoma.